drugset / Trial / NCT00797550
Use of TRC Autologous Bone Marrow Cells in Posterolateral Lumbar Spine Fusion
RandomizedParallel-groupOpen-labelTreatment
Summary
The hypothesis is that Aastrom TRC autologous bone marrow tissue "grafts" can be safely used to promote bone healing as part of a single level posterolateral spine fusion surgical procedure.
Timeline
- Start
- 2006-04
- Primary completion
- 2006-08
- Completion
- 2008-10
Outcome
Outcome not reported
Stopped (Business): “Study was terminated early for business reasons (not safety reasons).”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bone Repair Cells | Unknown | — | — |
Indications
No indication recorded.